Agency for Healthcare Research and Quality (AHRQ)

AHRQ — the Agency for Healthcare Research and Quality — is the federal government's primary research agency focused not on discovering new treatments (that's NIH's job) but on understanding what works in health care delivery: which treatments are actually effective in practice, which providers deliver better outcomes, where health care disparities exist, and how to make medical care safer and more efficient. Established by the Healthcare Research and Quality Act of 1999 and codified at 42 U.S.C. § 299, AHRQ funds comparative effectiveness research, patient safety improvements, and health IT standards — making it the evidence base behind policies that determine what Medicaid and Medicare pay for, how hospitals are rated, and what clinical guidelines say. For the HITECH Act's health IT provisions that AHRQ's research helps implement, and the HIPAA privacy framework that governs the health data AHRQ uses, see those pages. For every dollar spent on health care, AHRQ is the agency asking whether that dollar is well spent.

Current Law (2026)

Legal Authority

• 42 U.S.C. § 299 — Mission and establishment: AHRQ is established within the Public Health Service; the Director carries out research to improve the quality, safety, effectiveness, and efficiency of health care; to reduce health disparities; and to improve access to health services
• 42 U.S.C. § 299a — General authorities: the Director conducts and supports research, evaluations, training, and demonstration projects; supports research networks and multidisciplinary centers; provides technical assistance; and disseminates information to make evidence available to practitioners, policymakers, and patients
• 42 U.S.C. § 299a-1 — Health disparities research: the Director must conduct and support research to identify populations with significant disparities in quality, outcomes, cost, or access; measure disparities; and identify effective strategies to eliminate disparities
• 42 U.S.C. § 299b — Health care quality: research on outcomes, effectiveness, and appropriateness of health care services and their impact on access, cost, and quality; development of quality measures used in federal programs
• 42 U.S.C. § 299b-1 — Patient safety organization program: establishes a framework for Patient Safety Organizations (PSOs) that collect and analyze patient safety events in a legally protected environment; the PSQIA data contributed to PSOs is privileged and confidential

Implementing Regulations

The AHRQ regulations implementing the Patient Safety and Quality Improvement Act (PSQIA) live at 42 CFR Part 3 — Patient Safety Organizations and Patient Safety Work Product. Part 3 establishes the legal framework under which healthcare providers can voluntarily share adverse event data, near-misses, and safety analyses with certified Patient Safety Organizations without fear that information will be used against them in litigation:

• § 3.10 — Purpose: implements PSQIA (P.L. 109-41) by creating the PSO program and defining "patient safety work product" — the data that receives federal privilege and confidentiality protection; PSQIA's core insight is that fear of liability was suppressing honest reporting of medical errors, preventing systemwide learning
• § 3.102 — PSO listing requirements: any entity can apply to AHRQ for PSO listing; the PSO must be a legally separate entity from the healthcare providers it works with, must have trained staff to collect and analyze patient safety data, must operate a patient safety evaluation system (PSES), and must contract with providers to receive their work product; AHRQ lists qualified PSOs on the publicly accessible PSO registry at pso.ahrq.gov
• § 3.106 — Security requirements: PSOs must implement specific information security controls — access controls, audit controls, integrity controls, and transmission security — for all patient safety work product; security requirements apply to any system that stores or transmits PSWP regardless of medium
• § 3.204 — Privilege: patient safety work product (PSWP) is privileged and cannot be used in any Federal, State, local, or Tribal civil, criminal, or administrative proceeding; cannot be subject to discovery, subpoena, or compelled disclosure; this federal preemption overrides any state discovery rule that might otherwise require production — the privilege is absolute within its scope
• § 3.206 — Confidentiality: PSWP is confidential and cannot be disclosed by a PSO or provider; the confidentiality rule has narrow exceptions — disclosure to authorized personnel within the same provider organization, disclosure to the PSO for analysis, disclosure to AHRQ upon request for compliance review, and nonidentifiable research data — but does not include disclosure in litigation or to regulators conducting enforcement actions against providers
• § 3.208 — Continued protection: PSWP does not lose its privilege or confidentiality protection if it is disclosed in error or without authorization; the protection "attaches" to the information itself, not just to its original location — a disclosure cannot retroactively strip the protection (except for criminal proceedings where disclosure was ordered under specific PSQIA exceptions)
• § 3.212 — Nonidentification: PSWP can be de-identified and shared for research and learning; AHRQ's Network of Patient Safety Databases (NPSD) aggregates de-identified PSWP across all PSOs to identify national patterns in patient safety events — this aggregate data is the public benefit the law was designed to produce

The practical operation: a hospital creates a patient safety evaluation system (PSES) — typically a reporting platform — and signs a written agreement with a listed PSO. Events reported into the PSES (near-misses, adverse events, safety hazards) become PSWP and receive federal privilege. The PSO analyzes the data, identifies patterns, and provides feedback to the provider. The hospital's risk management department and legal team do NOT have access to PSWP — the separation is legally required. As of 2024, AHRQ lists approximately 90 active PSOs covering providers in all 50 states; large hospital systems often work with specialized PSOs aligned with their clinical focus areas.

Recent rulemakings: The Part 3 framework has been relatively stable since its 2008 promulgation; 81 FR 61560 (September 2016) was the most recent notable amendment, clarifying definitions and the scope of what constitutes patient safety work product.

What AHRQ Actually Does

Comparative effectiveness research (CER) answers the question: "Of the available treatments for this condition, which works better, for whom, and under what circumstances?" Unlike basic biomedical research (discovering mechanisms) or FDA drug approval (does this drug work better than placebo), CER compares treatments head-to-head in real-world practice. AHRQ funds these systematic reviews through its Effective Health Care Program, which synthesizes existing evidence into reports used by guideline developers and payers.

Patient Safety Network (PSNet) is AHRQ's platform for learning from medical errors. The agency funds research on the causes of medical errors (wrong-site surgery, medication errors, diagnostic errors), the conditions that produce them (staffing levels, communication failures, cognitive overload), and interventions that prevent them. Hospital safety ratings and CMS value-based purchasing programs draw on AHRQ-developed measures.

Healthcare Cost and Utilization Project (HCUP) is one of the largest health data repositories in the United States, covering 97 million hospitalizations per year. Researchers, policymakers, and journalists use HCUP data to analyze hospital utilization, costs, charges, and quality across states and demographics. This is the database behind most studies you see about "hospitalizations for X increased by Y%."

National Healthcare Quality and Disparities Report (NHQDR): Published annually, the NHQDR measures how U.S. health care is performing on hundreds of quality measures, disaggregated by race, ethnicity, income, insurance status, and geography. It is the primary federal accountability document for health care quality improvement and disparity reduction.

Health IT and interoperability: AHRQ has funded substantial work on electronic health records, health information exchange, and clinical decision support — the digital infrastructure underlying modern health care delivery. The agency's research has shaped federal meaningful use standards and interoperability rules.

AHRQ and the Research-Policy Feedback Loop

AHRQ occupies a specific niche in the health policy ecosystem:

• NIH discovers: basic biomedical research, clinical trials, new drugs and treatments
• FDA approves: determines what drugs and devices are safe and effective enough to market
• AHRQ evaluates: determines how approved treatments compare to each other in practice, and how delivery systems can be improved
• CMS pays: uses AHRQ evidence to design Medicare/Medicaid payment policies and quality programs

Congress has explicitly prohibited AHRQ from conducting research "that mandates, defines, or recommends a specific coverage, payment, or treatment standard for any payer or provider." This provision — inserted after insurers objected to early AHRQ work on coverage appropriateness — limits AHRQ's ability to directly drive coverage decisions, but its systematic reviews are widely used by the private sector organizations that do make such decisions.

How It Affects You

If you're a patient choosing a hospital or provider: The clinical guidelines your doctor follows — for managing blood pressure, deciding when to order imaging for back pain, or recommending a procedure — are often built on systematic reviews of evidence that AHRQ commissions. When your hospital uses a surgical checklist, a sepsis recognition protocol, or a fall prevention bundle, the research demonstrating those practices save lives typically traces to AHRQ-funded studies. You can see how your hospital performs on safety and quality measures at the CMS Care Compare tool (medicare.gov/care-compare), which draws on AHRQ-developed quality measures. If you're choosing between hospitals for a non-emergency procedure, AHRQ's data is one input alongside CMS star ratings and The Leapfrog Group's Hospital Safety Grades (hospitalsafetygrade.org).

If you're a hospital patient concerned about safety: AHRQ's Patient Safety Organization (PSO) program lets hospitals report near-misses, errors, and adverse events to legally protected organizations without fear the reports will be used in litigation against them. This confidentiality — established by the Patient Safety and Quality Improvement Act (PSQIA) — was designed to encourage honest reporting so the health care system can learn from mistakes. If your hospital participates in a PSO, its safety event data is contributing to national learning that eventually improves care everywhere — including lessons that become the next generation of safety checklists. AHRQ's CUSP (Comprehensive Unit-based Safety Program) methodology, developed through AHRQ-funded research, dramatically reduced central line infections in ICUs and is now standard practice across thousands of U.S. hospitals.

If you work in health care quality, research, or policy: AHRQ's free, peer-reviewed resources are essential infrastructure for health policy work: the Effective Health Care Program (effectivehealthcare.ahrq.gov) publishes comparative effectiveness reviews for over 500 topics; the Healthcare Cost and Utilization Project (hcup-us.ahrq.gov) covers 97 million hospitalizations annually with detailed charge and diagnosis data available to qualified researchers; and the National Healthcare Quality and Disparities Report (ahrq.gov/research/findings/nhqrdr) tracks hundreds of quality measures disaggregated by race, ethnicity, insurance status, and income — the primary federal accountability document for health care quality improvement. AHRQ's PSNet (psnet.ahrq.gov) curates patient safety literature and case studies. For grant funding, AHRQ issues competitive grants and contracts across three research programs — Health Services Research, Patient Safety, and Health IT — at grants.ahrq.gov.

If you're an employer or benefits administrator: AHRQ's comparative effectiveness research identifies high-value care (strong evidence, proven outcomes) versus low-value care (weak evidence, common overuse). Employers and insurers use this evidence to design benefit plans that cover high-value care generously while applying prior authorization or cost sharing to low-value care — for example, AHRQ-funded evidence on spinal fusion surgery's limited effectiveness for non-specific low back pain has influenced which procedures require additional review. While AHRQ is legally prohibited from directly mandating coverage decisions, its systematic reviews directly inform private-sector organizations (ICER, ECRI, the National Comprehensive Cancer Network) that do shape coverage policy. Ask your health plan's clinical coverage team how evidence from AHRQ's Effective Health Care Program factors into their coverage determinations for high-cost procedures.

State Variations

AHRQ is a federal agency but its research and data tools (including HCUP state-level databases) are heavily used by state health departments, Medicaid agencies, and state-based quality improvement organizations.

Pending Legislation

No major structural changes to AHRQ are pending as of April 2026. AHRQ's budget has been politically contested — it was nearly eliminated in 2017 budget proposals but survived. The agency's role in comparative effectiveness research remains stable.

Recent Developments

• Trump FY2026 budget proposed eliminating AHRQ: The Trump administration's FY2026 budget proposal, released in 2025, proposed eliminating AHRQ entirely — moving any retained research functions to NIH or other HHS components. This is not a new proposal; Republicans have periodically targeted AHRQ as duplicative of NIH work, too focused on "comparative effectiveness" research that could be used to ration care, or unnecessary bureaucracy. AHRQ survived similar elimination proposals in the Obama and Trump first-term budgets through Congressional action. As of April 2026, no legislation has enacted AHRQ's elimination; Congress has historically protected the agency on a bipartisan basis. But the proposal signals reduced administrative support and potential budget pressure even short of elimination.
• DOGE-era staffing and grant freezes disrupted ongoing research: As part of the Trump administration's early-2025 DOGE-driven federal workforce reductions and grant reviews, AHRQ experienced temporary freezes on grant disbursements and staff reassignments. Ongoing multi-year research projects — health disparities studies, patient safety improvement grants to hospitals, and the Healthcare Cost and Utilization Project (HCUP) database maintenance — experienced disruptions. HCUP, which provides researchers and policymakers with hospitalization data used to track everything from opioid mortality to COVID outcomes, is built on state data partnerships that require sustained federal coordination; interruptions damage the infrastructure that takes years to build.
• Clinical Practice Guidelines Clearinghouse shut down in 2018 — vacuum persists: AHRQ shut down its National Guideline Clearinghouse in 2018 due to funding constraints. The Clearinghouse had been the primary repository of evidence-based clinical practice guidelines for U.S. physicians — guidelines used by insurers to determine coverage and by clinicians for treatment decisions. After its closure, no single authoritative federal clearinghouse replaced it. Various specialty medical societies maintain their own guidelines, but the fragmented landscape means less cross-comparison and potential inconsistency. A 2025 GAO report identified this gap as a continuing problem for evidence-based care delivery; AHRQ has not restored the clearinghouse as of April 2026.
• Healthcare quality measurement remains AHRQ's most durable contribution: AHRQ's National Healthcare Quality and Disparities Report — an annual assessment of quality and disparities across the U.S. healthcare system — is one of the few federal publications providing rigorous annual tracking of health outcomes by race, income, and geography. The 2024 report documented persistent disparities in maternal mortality, diabetes management, and preventive care access. This measurement infrastructure informs CMS's value-based purchasing programs and state Medicaid quality improvement efforts. Even administrations that propose AHRQ's elimination have not abolished the underlying quality measurement mandate in statute.